ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,292 | -3.0% | 21,590 | 0.0% | 0.00% | – |
| Q2 2023 | $79,667 | +24.5% | 21,590 | +11.4% | 0.00% | – |
| Q1 2023 | $64,000 | +30.6% | 19,373 | +51.0% | 0.00% | – |
| Q4 2022 | $49,000 | -14.0% | 12,829 | -55.5% | 0.00% | – |
| Q2 2022 | $57,000 | +9.6% | 28,833 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | +116.7% | 28,833 | +55.4% | 0.00% | – |
| Q4 2021 | $24,000 | +20.0% | 18,552 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -31.0% | 18,552 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -12.1% | 18,552 | 0.0% | 0.00% | – |
| Q1 2021 | $33,000 | +6.5% | 18,552 | +14.2% | 0.00% | – |
| Q4 2020 | $31,000 | +40.9% | 16,242 | +55.4% | 0.00% | – |
| Q3 2020 | $22,000 | – | 10,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |